Skip to Content
  1. All products
  2. Weight Management
  3. Tesamorelin
  4. Weight Management
Pricelist: Default Pricelist Pricelist
Pricelist: Default Pricelist Pricelist
Tesamorelin

Tesamorelin

Lyophilized Vial · Subcutaneous Refrigerate 2–8°C · 18-month shelf life 99% Purity · USP Grade
99% Purity
PHYSICIAN USE ONLY
$ 57.00 $ 57.00

Format
💉 vial
  • Strength
Add to cart
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Clinical Description

Visceral fat reduction, muscle tone improvement, anti-aging, lean body mass development, fat loss, metabolic marker improvement

Tesamorelin es un péptido sintético que estimula la liberación de la hormona del crecimiento (GH) actuando como un análogo de la hormona liberadora de la hormona del crecimiento (GHRH). Originalmente aprobado por FDA para la lipodistrofia relacionada con el VIH, ahora se usa ampliamente de forma no autorizada para reducir la grasa visceral, mejorar el tono muscular y apoyar el antienvejecimiento. Tesamorelin promueve el desarrollo de masa corporal magra, la pérdida de grasa y la mejora de los marcadores metabólicos.

Clinical Indications
Visceral Fat ReductionHIV LipodystrophyMetabolic SyndromeGH OptimizationBody Composition
Recommended Stacking Protocols
✓
Ipamorelin
Enhances pulsatile GH release
✓
5-Amino-1MQ
Complements metabolic benefits
✓
AOD-9604
For fat burning and body composition

Mechanism of Action - Growth Hormone Peptides Pathway

GHRH Receptor Agonism
Synthetic GHRH analogue stimulating pulsatile GH secretion from pituitary somatotropes.
Visceral Fat Reduction
GH-mediated lipolysis selectively targets visceral adipose tissue stores.
FDA-Validated
The only FDA-approved GHRH analogue with extensive clinical validation.
Starting Dose
0.5-1mg per day (up to 3x per day)
Initiation phase for tolerance and baseline response.
Titration
1–2 mg
Maintenance Range
2 mg
Adjust based on objective outcomes and physician review.
Suggested Dosing Notes

Dosis típica:0,5-1 mg por día (hasta 3 veces por día)

Frecuencia:Diaria, matutina o nocturna.(Se puede tomar mañana, tarde y noche)

Ciclo:De forma continua o en bloques de 8 a 12 semanas

Period Dose Phase Clinical Notes
Typical Dose 0.5-1mg per day (up to 3x per day) maintenance Daily, Morning or Nighttime. Ongoing or in 8-12 week blocks.
Week 5+ 2 mg maintenance Full clinical dose. Monitor GH and IGF-1 levels.
Preparation Protocol
  1. Tesamorelin se suministra como polvo liofilizado.
  2. Tesamorelin debe reconstituirse con agua bacteriostática antes de su uso.
  3. El volumen de reconstitución varía ligeramente según el tamaño del vial para mantener una dosificación sencilla.
1
Verify Lyophilized Powder
Confirm the vial contains an intact white or off-white powder cake. Check lot number and expiration date.
2
Gather Sterile Supplies
Required: bacteriostatic water (BW), 1 mL insulin syringe, alcohol swabs, sharps container. Confirm all supplies are sterile and within date.
⚠️ Use only bacteriostatic water. Standard sterile water significantly reduces peptide stability.
3
Select Reconstitution Volume
Choose BW volume based on vial size and target concentration. See Reconstitution Guide tab for exact volumes per strength.
4
Reconstitute the Vial
Wipe stopper with alcohol swab. Inject BW slowly along the glass wall — never directly onto the powder. Allow liquid to run down the sides.
⚠️ Do not shake. Gently swirl or roll between palms (30–60 sec). Shaking causes irreversible peptide degradation.
5
Inspect & Store
Solution should be clear and colorless or slightly yellow. Discard if cloudy or particulate. Store reconstituted at 2–8°C, use within 28 days. Label with date.
Reconstitution & Dosing Guide
Standard 1 mL insulin syringe: 100 units = 1 mL

Total Peptide: 5 mg
BW: 1 mL
Concentration: 5mg/mL (50mcg per unit)
Dose Units to Draw Volume (mL) Approx. Supply
0.5mg 10 units - 10 doses (1+ week)
1mg 20 units - 5 doses (0.5 week)
2mg 40 units - 2-3 doses

Total Peptide: 10 mg
BW: 2 mL
Concentration: 5mg/mL (50mcg per unit)
Dose Units to Draw Volume (mL) Approx. Supply
0.5mg 10 units - 20 doses (2+ weeks)
1mg 20 units - 10 doses (1+ weeks)
2mg 40 units - 5 doses (0.5 weeks)

Total Peptide: 15 mg
BW: 3 mL
Concentration: 5mg/mL (50mcg per unit)
Dose Units to Draw Volume (mL) Approx. Supply
0.5mg 10 units - 30 doses (3+ weeks)
1mg 20 units - 15 doses (2+ weeks)
2mg 40 units - 7 doses (1 week)

Total Peptide: 20 mg
BW: 3 mL
Concentration: ~6.67mg/mL (~66.7mcg per unit)
Dose Units to Draw Volume (mL) Approx. Supply
0.5mg ~7.5 units - 40 doses (4+ weeks)
1mg ~15 units - 20 doses (3 weeks)
2mg ~30 units - 10 doses (1.5 weeks)
Identity
  • Name: Tesamorelin
  • Product Type: Vial | Subcutaneous Injection
  • CAS Number: 218949-48-5
  • Available Strengths: 5mg, 10mg, 15mg, 20mg
  • Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₄S
  • Molecular Weight: 5,135.8 Da
  • Sequence / Type: GHRH analogue (1–44)
  • Available Strengths: 5mg, 10mg
Quality & Purity
  • Purity: 99%+
  • Purity: ≥ 99%
  • Endotoxin: ≤ 1 EU/mg
  • Appearance: White lyophilized powder
  • Solubility: Bacteriostatic water
Storage & Handling
  • Storage: Refrigerate after reconstitution (2-8°C)
  • Pre-use Storage: -20°C (long-term) / 2–8°C (short)
  • Post-Reconstitution: 2–8°C · Up to 28 days
  • Shelf Life: 18 months from manufacture

Timing: Daily,Morning or Nightime. (Canbetakenmorning,afternoon,nighttime）

Storage: Refrigerate 2–8°C · 18-month shelf life

Frequency: Frequency: Daily,Morning or Nightime.

Cycle: Ongoing or in 8-12 week blocks

Injection Sites: Rotate approved injection sites to reduce local irritation risk.